LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer
- PMID: 31210311
- DOI: 10.26355/eurrev_201906_18065
LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer
Abstract
Objective: To detect the relative expression of long non-coding ribonucleic acid (lncRNA) F-box and leucine-rich repeat protein 19-antisense RNA 1 (FBXL19-AS1) in tissues and cells of non-small-cell lung cancer (NSCLC), and investigate the mechanism of lncRNA FBXL19-AS1 in promoting NSCLC cell proliferation and metastasis by regulating epithelial-mesenchymal transition (EMT) via in vitro experiments.
Patients and methods: The relative expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells was detected via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The colony formation assay was performed to study the impact of interference with lncRNA FBXL19-AS1 expression on NSCLC cell proliferation. The flow cytometry was applied to determine the influence of si-FBXL19-AS1 on the cycle distribution of NSCLC cells. After the interference with lncRNA FBXL19-AS1 expression, the transwell assay was utilized to measure the changes in the migratory and invasive abilities of NSCLC cells, while the expression changes in EMT-related molecular markers was detected via Western blotting.
Results: The results of qRT-PCR showed that the expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells was up-regulated. According to the results of the colony formation assay, the proliferative capacity of NSCLC cells was decreased after the interference with lncRNA FBXL19-AS1 expression. In flow cytometry, it was indicated that the cell cycle was arrested at the G0/G1 phase in the experimental group compared with that in the control group. The transwell assay results showed that the migratory and invasive abilities of NSCLC cells were weakened after the interference with lncRNA FBXL19-AS1 expression. The results of the Western blotting assay revealed that the expressions of EMT-related molecular markers (E-cadherin, N-cadherin, etc.) were changed.
Conclusions: The expression of lncRNA FBXL19-AS1 in NSCLC tissues and cells is up-regulated, and the highly expressed lncRNA FBXL19-AS1 can promote NSCLC cell proliferation and metastasis by regulating the EMT.
Similar articles
-
FLVCR1-AS1 and FBXL19-AS1: Two Putative lncRNA Candidates in Multiple Human Cancers.Noncoding RNA. 2022 Dec 22;9(1):1. doi: 10.3390/ncrna9010001. Noncoding RNA. 2022. PMID: 36649030 Free PMC article. Review.
-
LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).Biomed Pharmacother. 2017 Nov;95:331-338. doi: 10.1016/j.biopha.2017.08.057. Epub 2017 Sep 12. Biomed Pharmacother. 2017. PMID: 28858731
-
LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1870-1876. doi: 10.26355/eurrev_202002_20365. Eur Rev Med Pharmacol Sci. 2020. Retraction in: Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1766. doi: 10.26355/eurrev_202102_25054. PMID: 32141556 Retracted.
-
LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4879-4887. doi: 10.26355/eurrev_201808_15624. Eur Rev Med Pharmacol Sci. 2018. PMID: 30070323
-
[Progress in Role of FEZF1-AS1 in Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2020 Apr 20;23(4):294-298. doi: 10.3779/j.issn.1009-3419.2020.101.05. Epub 2020 Apr 1. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32228826 Free PMC article. Review. Chinese.
Cited by
-
LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420958947. doi: 10.1177/2058738420958947. Int J Immunopathol Pharmacol. 2020. PMID: 32969763 Free PMC article.
-
Long Noncoding RNA FBXL19-AS1 Expedites Cell Growth, Migration and Invasion in Cervical Cancer by miR-193a-5p/PIN1 Signaling.Cancer Manag Res. 2020 Oct 7;12:9741-9752. doi: 10.2147/CMAR.S262215. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116834 Free PMC article.
-
IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay.RNA Biol. 2020 Dec;17(12):1777-1788. doi: 10.1080/15476286.2020.1795583. Epub 2020 Jul 25. RNA Biol. 2020. PMID: 32713259 Free PMC article.
-
FLVCR1-AS1 and FBXL19-AS1: Two Putative lncRNA Candidates in Multiple Human Cancers.Noncoding RNA. 2022 Dec 22;9(1):1. doi: 10.3390/ncrna9010001. Noncoding RNA. 2022. PMID: 36649030 Free PMC article. Review.
-
Downregulation of LINC00665 suppresses the progression of lung adenocarcinoma via regulating miR-181c-5p/ZIC2 axis.Aging (Albany NY). 2021 Jul 7;13(13):17499-17515. doi: 10.18632/aging.203240. Epub 2021 Jul 7. Aging (Albany NY). 2021. PMID: 34232917 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials